| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |